Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy

NCT01710176 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT01710176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy
Lead sponsor
Italian Sarcoma Group
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2011
Completion date
June 30, 2024
Enrollment
550 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

localized high-risk soft tissue sarcomas of the extremities and trunk wall in adults